2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow Transient Ischemic Attack: new trials by email Literature Review of Transient Ischemic Attack trials Research Report on Transient Ischemic Attack
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events dl-3-n-butylphthalide (NBP), Normal Saline 0.9% Infusion Solution - Moyamoya Disease, Ischemic Cerebral Infarction | Phase 3 | Unknown | yuanli Zhao | 450 | 2020-01-01 | 2019-12-19 |
| Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis Intensive antiplatelet, Standard antiplatelet, Immediate high-intensity statin - Acute Stroke, Transient Ischemic Attack | Phase 3 | Unknown | Beijing Tiantan Hospital | 6100 | 2018-09-17 | 2023-07-18 |
Ischemic Attack, Transient (2) · Ischemic Stroke (1) · Moyamoya Disease (1) · Stroke (1)
Brain Diseases (2) · Brain Ischemia (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Nervous System Diseases (2) · Vascular Diseases (2) · Arterial Occlusive Diseases (1) · Carotid Artery Diseases (1) · Cerebral Arterial Diseases (1) · Intracranial Arterial Diseases (1) · Stroke (1)
3-n-butylphthalide (1) · Aspirin (1) · Saline Solution (1)
Beijing Tiantan Hospital (1) · yuanli Zhao (1)
China (2)
Yilong Wang, MD, PhD (1) · Yuanli Zhao, MD (1)
PMID 36707080, PMID 38157499, PMID 38805216, PMID 39240565, PMID 39270151, PMID 39705390, PMID 39931900, PMID 40190261, PMID 40251953, PMID 40673545, PMID 40964718, PMID 41650951, PMID 41991239, PMID 42348803, PMID 42390058, PMID 42430849